Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.

about

Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.

Item

http://www.wikidata.org/entity/Q47142345

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@en

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@nl

type

Item

label

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@en

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@nl

prefLabel

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@en

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@nl

P1476

Novel elvitegravir nanoformula ...... d in HIV-infected macrophages.

@en

P2093

Mohammad A Rahman

http://www.w3.org/2001/XMLSchema#string

Murali M Yallapu

http://www.w3.org/2001/XMLSchema#string

Narasimha M Midde

http://www.w3.org/2001/XMLSchema#string

Pallabita Chowdhury

http://www.w3.org/2001/XMLSchema#string

Santosh Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Drug delivery and nanoparticles:applications and hazards

Current perspectives on HIV-1 antiretroviral drug resistance

CYP3A gene expression in human gut epithelium

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method

Current advances in research and clinical applications of PLGA-based nanotechnology.

HIV integrase inhibitors: a new era in the treatment of HIV.

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

Integrase inhibitors to treat HIV/AIDS.

Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies

P304

214-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBREP.2017.10.005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuqing Gong

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214223

http://www.w3.org/2001/XMLSchema#string

P921

viral load

P932

5704044

http://www.w3.org/2001/XMLSchema#string